Hospital Amaral Carvalho

São Paulo 17210080

4 studies enrolling now · 6 studies all time

What they study most

Adult Acute Myeloid Leukemia, Anaplastic Lymphoma Kinase-positive, Cervical Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC), Indolent B-Cell Non-Hodgkin Lymphoma, Non-small Cell Lung Cancer, PD-L1 Negative, Triple Negative Breast Cancer

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT — Recruiting now
• Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer — Recruiting now
• A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL — Recruiting now
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer — Stopped early